AKT1 and non-small cell lung carcinoma: The study verified the characteristics of multiple ingredients, targets, and pathways for YFSJF against NSCLC, with PIK3R1, PIK3CA, and AKT1 identified as the major targets associated with NSCLC patients' prognosis.